Activation of NK cell cytotoxicity.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Immunology

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MOLIMM.2004.07.034PMID 15607806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cloning and expression of the recombinant mouse natural killer cell granzymeMet-ase-1

  2007cited by this paper
• Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells

  2004cited by this paper
• NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy 1

  2004cited by this paper
• The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11-q12 and define a new locus for cytotoxic lymphocyte granule tryptases

  2004cited by this paper
• Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway1

  2004cited by this paper
• Granzyme M Mediates a Novel Form of Perforin-dependent Cell Death*

  2004cited by this paper
• Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates.

  2004cited by this paper
• IL-21 Induces the Functional Maturation of Murine NK Cells 1

  2004cited by this paper
• Nature's TRAIL--on a path to cancer immunotherapy.

  2003cited by this paper
• Granulysin.

  2003cited by this paper
• NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules

  2003cited by this paper
• The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic Proteins

  2003cited by this paper
• NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases

  2003cited by this paper
• Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A

  2003cited by this paper
• Cutting Edge: Granzymes A and B Are Not Essential for Perforin-Mediated Tumor Rejection

  2003cited by this paper
• Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection

  2003cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.

  2003cited by this paper
• Requirement for NK Cells in CD40 Ligand-Mediated Rejection of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Cells

  2002cited by this paper
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1

  2002cited by this paper
• Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

  2002cited by this paper
• Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

  2002cited by this paper
• The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

  2002cited by this paper
• Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

  2002cited by this paper
• Inducible Costimulator Costimulates Cytotoxic Activity and IFN-γ Production in Activated Murine NK Cells1

  2002cited by this paper
• A Role for IFN-γ in Primary and Secondary Immunity Generated by NK Cell-Sensitive Tumor-Expressing CD80 In Vivo1

  2002cited by this paper
• Recognition of a virus-encoded ligand by a natural killer cell activation receptor

  2002cited by this paper
• Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

  2002cited by this paper
• Cutting Edge: Tumor Rejection Mediated by NKG2D Receptor-Ligand Interaction Is Dependent upon Perforin1

  2002cited by this paper
• Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation.

  2002cited by this paper
• Functional significance of the perforin/granzyme cell death pathway

  2002cited by this paper
• New aspects of natural-killer-cell surveillance and therapy of cancer

  2002cited by this paper
• MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo

  2002cited by this paper
• Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

  2001cited by this paper
• Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells1

  2001cited by this paper
• Granzyme A and B‐deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti‐tumor capacity

  2001cited by this paper
• Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β 

  2001cited by this paper
• Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

  2001cited by this paper
• Natural killer cells, viruses and cancer

  2001cited by this paper
• Specific and nonspecific NK cell activation during virus infection

  2001cited by this paper
• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

  2001cited by this paper
• Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

  2001cited by this paper
• ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

  2001cited by this paper
• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.

  2001cited by this paper
• Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily

  2001cited by this paper
• Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection

  2001cited by this paper
• A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells1

  2001cited by this paper
• Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Contributes to Interferon γ–Dependent Natural Killer Cell Protection from Tumor Metastasis

  2001cited by this paper
• Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice.

  2000cited by this paper
• Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

  2000cited by this paper
• Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages

  2000cited by this paper
• CD27-Mediated Activation of Murine NK Cells1

  2000cited by this paper
• Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

  2000cited by this paper
• The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent1

  2000cited by this paper
• Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.

  2000cited by this paper
• Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation.

  1999cited by this paper
• Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes.

  1999cited by this paper
• Cytosolic Delivery of Granzyme B by Bacterial Toxins: Evidence that Endosomal Disruption, in Addition to Transmembrane Pore Formation, Is an Important Function of Perforin

  1999cited by this paper
• Natural killer cells in antiviral defense: function and regulation by innate cytokines.

  1999cited by this paper
• Triggering of murine NK cells by CD40 and CD86 (B7-2).

  1999cited by this paper
• To die or not to die—the quest of the TRAIL receptors

  1999cited by this paper
• Perforin Is Essential for Control of Ectromelia Virus but Not Related Poxviruses in Mice

  1999cited by this paper
• Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

  1999cited by this paper
• Perforin is a major contributor to NK cell control of tumor metastasis.

  1999cited by this paper
• T-cell co-stimulation through B7RP-1 and ICOS

  1999cited by this paper
• ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

  1999cited by this paper
• Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo.

  1999cited by this paper
• Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.

  1999cited by this paper
• Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.

  1999cited by this paper
• Control of lymphocyte function through CD27-CD70 interactions.

  1998cited by this paper
• Gene Structure, Expression Pattern, and Biological Activity of Mouse Killer Cell Activating Receptor-associated Protein (KARAP)/DAP-12*

  1998cited by this paper
• Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways.

  1998cited by this paper
• Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.

  1998cited by this paper
• Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells.

  1998cited by this paper
• NK cell receptors.

  1998cited by this paper
• Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.

  1998cited by this paper
• An Essential Role for Tumor Necrosis Factor in Natural Killer Cell–mediated Tumor Rejection in the Peritoneum

  1998cited by this paper
• An antimicrobial activity of cytolytic T cells mediated by granulysin.

  1998cited by this paper
• Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells

  1997cited by this paper
• A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction

  1997cited by this paper
• Localization of Granzyme B in the Nucleus

  1996cited by this paper
• Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1.

  1996cited by this paper
• Long-range disruption of gene expression by a selectable marker cassette.

  1996cited by this paper
• Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies

  1996cited by this paper
• Perforin dependence of natural killer cell‐mediated tumor control in vivo

  1995cited by this paper
• A family of murine NK cell receptors specific for target cell MHC class I molecules.

  1995cited by this paper
• Granzymes: exogenous proteinases that induce target cell apoptosis.

  1995cited by this paper
• Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.

  1995cited by this paper
• Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I.

  1995cited by this paper
• Granzyme A‐deficient mice retain potent cell‐mediated cytotoxicity.

  1995cited by this paper
• Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

  1994cited by this paper
• Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells.

  1994cited by this paper
• Met-ase: cloning and distinct chromosomal location of a serine protease preferentially expressed in human natural killer cells.

  1993cited by this paper
• Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions

  1992cited by this paper
• Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.

  1992cited by this paper
• Purification and cloning of a novel serine protease, RNK-Met-1, from the granules of a rat natural killer cell leukemia.

  1992cited by this paper
• Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen

  1990cited by this paper

• Bromodomain and extra-terminal proteins in solid tumors: regulators of immune microenvironment and emerging therapeutic targets

  2026cites this paper
• Lemon gum (Citrus x latifolia) enhances IL-1Β expression and suppresses colon tumor growth in vivo with a favorable safety profile.

  2026cites this paper
• Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters

  2026cites this paper
• Reduction of the HIV-1 reservoir in T cells from people with HIV-1 on suppressive antiretroviral therapy using expanded natural killer cells

  2026cites this paper
• Prophylactic monoclonal antibodies against respiratory syncytial virus in early life: An in‐depth review of mechanisms of action, failure factors, and future perspectives

  2025cites this paper
• Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity

  2025cites this paper
• Advances in CAR‐T therapy for small cell lung cancer

  2025cites this paper
• Anticancer effects of thymoquinone on prostate cancer cells and natural killer cell activity

  2025cites this paper
• Translational Insights into NK Immunophenotyping: Comparative Surface Marker Analysis and Circulating Immune Cell Profiling in Cancer Immunotherapy

  2025cites this paper
• N6-methyladenosine RNA base modification regulates NKG2D-dependent and cytotoxic genes expression in natural killer cells

  2025cites this paper
• Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors

  2025cites this paper
• Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

  2025cites this paper
• Senescence, NK cells, and cancer: navigating the crossroads of aging and disease

  2025cites this paper
• Anti-SARS-CoV-2 and Immunomodulatory Activity of Marine Bacteria Polysaccharides

  2025cites this paper
• The immune microenvironment in tumors: focus on canine and feline spontaneous neoplasms

  2025cites this paper
• Adaptive NKG2C+ NK cells in cytomegalovirus seropositive individuals predominantly lack NKR‐P1A receptor expression

  2025cites this paper
• A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors.

  2025cites this paper
• CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment.

  2025cites this paper
• Application of a novel branched-DNA assay to quantify killer immunoglobulin-like receptor (KIR) mRNA expression identifies tissue compartmentalization in naïve and SIV-infected rhesus macaques.

  2025cites this paper
• Quantification of timelapse 3D tumor spheroid killing activity of NK cells using a live-cell imaging system

  2025cites this paper
• Immunostimulating and Anticancer Activities of the Pectic Polysaccharide from Panax ginseng Leaves Treated with High Pressure/Enzyme Process

  2025cites this paper
• Mechanistic insights into molecular targeted therapy and immunotherapy for lung cancer.

  2025cites this paper
• Enhanced Immune Functions of In Vitro Human Natural Killer Cells and Splenocytes in Immunosuppressed Mice Supplemented with Mature Silkworm Products

  2025cites this paper
• Exploring the potential of CAR-NK cell therapy in the management of head and neck cancer (HNC): a narrative review

  2025cites this paper
• Multivalent aptamer engineered and functionalized NK cells for enhanced adoptive immunotherapy in CD30-positive malignant lymphoma

  2025cites this paper
• Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review

  2025cites this paper
• FcRn inhibitors in immune thrombocytopenia: A comprehensive review of therapeutic advances and clinical outcomes.

  2025cites this paper
• Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy.

  2025cites this paper
• Host-Directed Insights into Mycobacterial Infections: Toward Targeted Immunomodulation.

  2025cites this paper
• Natural Killer (NK) Cell Alloreactivity in Haploidentical Stem Cell Transplantation

  2025cites this paper
• Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives

  2024cites this paper
• Active role of the immune system in metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor–Ligand Interactions and Soluble Factor Profiles

  2024cites this paper
• Dysregulation of immune tolerance to autologous iPSCs and their differentiated derivatives (review)

  2024cites this paper
• Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance

  2024cites this paper
• Rational design of ROS generation nanosystems to regulate innate immunity of macrophages, dendrtical and natural killing cells for immunotherapy.

  2024cites this paper
• Upregulation of NK cell activity, cytokine expression, and NF-κB pathway by ginsenoside concentrates from Panax ginseng berries in healthy mice and macrophage cell lines.

  2024cites this paper
• The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View

  2024cites this paper
• Advances in CAR-NK cell therapy for hematological malignancies

  2024cites this paper
• Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras/Raf signalling pathways

  2024cites this paper
• Surfactant Protein-A (SP-A) and its Immunomodulatory Roles in Infant Respiratory Syncytial Virus (RSV) Infection - a potential for therapeutic intervention?

  2024cites this paper
• Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases

  2024cites this paper
• Lacticaseibacillus casei K11 exerts immunomodulatory effects by enhancing natural killer cell cytotoxicity via the extracellular regulated-protein kinase pathway

  2024cites this paper
• Increasing Natural Killer Cell Activity of Mineral Nanomaterial ALP1018 in Healthy Adults: A Randomized, Double-Blind, Placebo Comparative Clinical Trial

  2024cites this paper
• Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study

  2024cites this paper
• B cell clonality in cancer.

  2024cites this paper
• Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

  2024cites this paper
• Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies

  2024cites this paper
• Immunotherapy for hepatocellular carcinoma

  2024cites this paper
• Natural killer cells in cancer immunotherapy

  2024cites this paper
• Immunity on ice: The impact of methamphetamine on peripheral immunity.

  2024cites this paper
• Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)

  2024cites this paper
• Guardians of immunity: NK cell-mediated defense in COVID-19 and post-COVID scenarios.

  2024cites this paper
• Natural killer cell-derived exosome-based cancer therapy: from biological roles to clinical significance and implications

  2024cites this paper
• GD2-targeting therapy: a comparative analysis of approaches and promising directions

  2024cites this paper
• Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

  2024influential citation
• Therapeutic antibodies in oncology: an immunopharmacological overview

  2024cites this paper
• CD56-targeted in vivo genetic engineering of natural killer cells mediates immunotherapy for acute myeloid leukemia.

  2024cites this paper
• Antileukemia Activity of Human Natural Killer Cell-Derived Nanomagic Bullets against Acute Myeloid Leukemia (AML)

  2024cites this paper
• Engineered Cellular Therapies for the Treatment of Thoracic Cancers

  2024cites this paper
• NK cells as powerful therapeutic tool in cancer immunotherapy

  2024cites this paper
• Effects of mealworm hydrolysates on improving immune function and gut microbiota in cyclophosphamide-induced mice

  2024cites this paper
• Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors

  2024cites this paper
• NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment

  2024cites this paper
• Different evasion strategies in multiple myeloma

  2024cites this paper
• Thetumor microenvironment'sinpancreatic cancer:Effects onimmunotherapy successandnovel strategiestoovercomethehostile environment.

  2024cites this paper
• Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy

  2024cites this paper
• Immunometabolic features of natural killer cells are associated with infection outcomes in critical illness

  2024cites this paper
• The multifaceted role of SMAD4 in immune cell function

  2024cites this paper
• Potentiation of Antitumor Activity by Antibody Drugs and Mushroom-Derived β-Glucans in Natural Killer Cell-Mediated Tumoricidal Activities against Non-Hodgkin's B-Cell Lymphoma.

  2023cites this paper
• Unraveling the role of natural killer cells in leishmaniasis.

  2023cites this paper
• Tailoring tumor-recognizable hyaluronic acid–lipid conjugates to enhance anticancer efficacies of surface-engineered natural killer cells

  2023cites this paper
• Therapeutic avenues for γδ T cells in cancer

  2023cites this paper
• ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4

  2023cites this paper
• Effect of Ethanol-exposure on Innate Immune Response in Sepsis.

  2023cites this paper
• Dietary melatonin positively impacts the immune system of crayfish, Cherax destructor, as revealed by comparative proteomics analysis.

  2023cites this paper
• Harnessing the immunomodulatory effects of exercise to enhance the efficacy of monoclonal antibody therapies against B-cell haematological cancers: a narrative review

  2023cites this paper
• Cytotoxic activity and gene expression during in vitro adaptive cell-mediated cytotoxicity of head-kidney cells from betanodavirus-infected European sea bass.

  2023cites this paper
• Effector and cytolytic function of natural killer cells in anti-cancer immunity.

  2023cites this paper
• Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19

  2023cites this paper
• Investigating the relationship between the number and activity of natural killer cells with increased cytomegalovirus and CMV disease after kidney transplantation.

  2023cites this paper
• Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments

  2023cites this paper
• Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy

  2023cites this paper
• Upregulation of CD226 on subsets of T cells and NK cells is associated with upregulated adhesion molecules and cytotoxic factors in patients with tuberculosis.

  2023cites this paper
• The estrogen/miR‐338‐3p/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function

  2023cites this paper
• Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells

  2023cites this paper
• Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells

  2023cites this paper
• Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform

  2023cites this paper
• Features of lymphocyte subset composition in neonates born to mothers suffered from COVID-19 at different stages of pregnancy

  2023cites this paper
• Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization

  2023cites this paper
• Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms

  2023cites this paper
• Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges

  2023cites this paper
• The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy

  2023cites this paper
• Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses

  2023cites this paper
• Contribution of natural killer cells in innate immunity against colorectal cancer

  2023cites this paper
• Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

  2023cites this paper
• Refurbishment of NK cell effector functions through their receptors by depleting the activity of nTreg cells in Dalton’s Lymphoma-induced tumor microenvironment: an in vitro and in vivo study

  2022cites this paper
• Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

  2022cites this paper
• Emerging Antibodies in Cancer Therapy

  2022cites this paper
• Metabolic regulation of immune responses to cancer

  2022cites this paper